Curve Therapeutics, a UK-based private biotechnology company, announced on Tuesday that it has named Simon Jones as its new chief financial officer (CFO) and chief operating officer (COO).

Jones has more than 20 years of experience in the biotech and pharma sector. He previously headed the Finance and Operations functions at SpyBiotech, was CFO at Karus Therapeutics and CFO at various early-stage life sciences companies, including Eykona Technologies and Glide Pharmaceutical Technologies.

Simon Kerry, Curve Therapeutics chief executive officer, said: "Simon brings extensive financial experience at the leadership level from multiple clinical stage biotech companies. His appointment comes at a pivotal time as we look to expand our team, advance our proprietary Microcycle® discovery platform, and progress our pipeline of potential first-in-class assets."